RT Journal Article
T1 Severe hepatotoxicity secondary to nintedanib.
A1 Librero Jiménez, Marta
A1 Heredia Carrasco, Clara
A1 Fernández Cano, María Del Carmen
AB Nintedanib is a multikinase inhibitor used for the treatment of pulmonary idiopathic fibrosis. We present the first report published to date of severe hepatotoxicity and jaundice secondary to nintedanib.
SN 1130-0108
YR 2022
FD 2022
LK http://hdl.handle.net/10668/21700
UL http://hdl.handle.net/10668/21700
LA en
DS RISalud
RD Aug 5, 2025